TNYA

Tenaya Therapeutics, Inc. - Common Stock (TNYA)

About Tenaya Therapeutics, Inc. - Common Stock (TNYA)

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.

Details

Daily high

$0.71

Daily low

$0.67

Price at open

$0.68

52 Week High

$2.35

52 Week Low

$0.53

Market cap

152.3M

Dividend yield

Volume

3.7M

Avg. volume

1.9M

P/E ratio

-1.29

Tenaya Therapeutics, Inc. - Common Stock News